## BACKGROUND. Cancer patients with single tumors live longer today due to earlier detection and improved treatment methods. For this reason, the authors see more patients who develop a second primary tumor. The etiology of the second tumor can be the same as the first, whether treatment-induced or
β¦ LIBER β¦
Cellular immunity in patients with multiple primary tumors
β Scribed by Arie Bartal; Robert Haasz; Mariana Steiner; Yoram Cohen; Eliezer Robinson
- Publisher
- Springer-Verlag
- Year
- 1977
- Tongue
- English
- Weight
- 434 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lymphocyte subpopulations in patients wi
β
Eliezer Robinson; Ruth Segal; Lily Struminger; David Faraggi; Ruchama El'ad-Yaru
π
Article
π
1999
π
John Wiley and Sons
π
English
β 59 KB
π 2 views
The effect of ranitidine on cellular imm
β
Hans JΓΈrgen Nielsen; Henrik Nielsen; Flemming Moesgaard; Niels Tvede; Kim Klarlu
π
Article
π
1990
π
Springer-Verlag
π
English
β 709 KB
Multiple primary malignancies in patient
β
Volker Fendrich; Jens Waldmann; Detlef K. Bartsch; Katja Schlosser; Matthias Rot
π
Article
π
2008
π
John Wiley and Sons
π
English
β 68 KB
Cellular immunity in SSPE patients
β
H. W. Kreth; Y. M. Kaeckell; V. Meulen
π
Article
π
1974
π
Springer-Verlag
π
English
β 502 KB
Cellular immune functions in patients wi
β
Nitza Lahat; B. Glaser; Erga Nir; M. Rotem; M. Sheinfeld; Z. Kraiem
π
Article
π
1985
π
Elsevier Science
π
English
β 455 KB
Cellular immunity in cured cancer patien
β
Patrick L. Twomey; William J. Catalona; Paul B. Chretien
π
Article
π
1974
π
John Wiley and Sons
π
English
β 534 KB
Cellular immune competence was quantitated in 100 postoperative cancer patients considered clinically free of tumor and compared with that of 200 preoperative cancer patients and over 400 cancer-free persons. Immunity was assessed by in vitro phytohemagglutinin (PHA)-induced lymphocyte reactivity an